Recombinant ERCC1 anticorps

N° du produit ABIN7828192

Cet anticorps Lapin Monoclonal détecte spécifiquement ERCC1 dans IHC. Il présente une réactivité avec des échantillons de Humain, Souris et Rat.

Aperçu rapide pour Recombinant ERCC1 anticorps (ABIN7828192)

Antigène: ERCC1 (Excision Repair Cross Complementing Polypeptide-1 (ERCC1))

Type d'anticorp: Recombinant Antibody

Reactivité: Humain, Souris, Rat

Hôte: Lapin

Clonalité: Monoclonal

Conjugué: Cet anticorp ERCC1 est non-conjugé

Application: Immunohistochemistry (IHC)

Clone: A216

Détail du produit anti-ERCC1 anticorps

Fonction: Recombinant ERCC1 Monoclonal Antibody

Purification: Protein A purified

Immunogène: Recombinant human ERCC1 fragment

Isotype: IgG, kappa

Information d'application

Indications d'application: IHC 1:200-1:1000

Restrictions: For Research Use only

Stockage

Concentration: 1 mg/mL

Buffer: PBS, 50 % glycerol, 0.05 % Proclin 300, 0.05 % protein protectant.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C Valid for 12 months. Avoid freeze / thaw cycles.

Date de péremption: 12 months

Détails sur ERCC1

Antigène: ERCC1 (Excision Repair Cross Complementing Polypeptide-1 (ERCC1))

Autre désignation: ERCC1

Sujet: Ercc,ERCC1,COFS 4,COFS4,DNA excision repair protein ERCC 1,DNA excision repair protein ERCC1,DNA excision repair protein ERCC-1,endonuclease non-catalytic subunit,ERCC 1,ERCC excision repair 1,Excision repair cross complementation group 1,Excision repair cross complementing 1,Excision Repair Cross Complementing Rodent Repair Deficiency Complementation Group 1,excision repair cross-complementation group 1,Excision repair protein,RAD 10,RAD10,UV 20,UV20,Non-catalytic component of a structure-specific DNA repair endonuclease responsible for the 5'-incision during DNA repair. Participates in the processing of anaphase bridge-generating DNA structures, which consist in incompletely processed DNA lesions arising during S or G2 phase, and can result in cytokinesis failure. Cat.No. Product Name Clone No. IF:{{item.impact}} Journal:{{item.journal}} ({{item.year}}) DOI:{{item.doi}} Reactivity:{{item.species}} Sample Type:{{item.sample_type}} Previous {{ page }} Next Q{{(FAQpage.currentPage - 1)*pageSize+index+1}}:{{item.name}} Previous {{ page }} Next [

UniProt: P07992

Pathways: Réparation de l'ADN, Production of Molecular Mediator of Immune Response